science wire

« BACK

Pharmacology



Results 1 - 50 of 2999.
1 2 3 4 5 ... 60 Next »


Health - Pharmacology - 30.06.2022
’Long COVID’ presents a major health challenge - how can Australia be prepared?
Triple vaccination seems to reduce the chance of long COVID - but we still need to prepare for a jump in cases, write researchers at the University of Sydney.

Health - Pharmacology - 29.06.2022
Q&A: What you should know about new COVID vaccines for young kids
Q&A: What you should know about new COVID vaccines for young kids
Vaccines against COVID-19 are finally available for the youngest Americans. The U.S. Food and Drug Administration voted on June 17 to authorize shots from Moderna and Pfizer for children as young as 6 months.

Health - Pharmacology - 29.06.2022
UCLA survey quantifies COVID-19 vaccine hesitancy among Californians
UCLA survey quantifies COVID-19 vaccine hesitancy among Californians
Despite the U.S. Food and Drug Administration's full approval of the COVID-19 vaccine, 58.8% of Californians who are not fully vaccinated are still worried about its side effects, according to a new UCLA survey.

Health - Pharmacology - 27.06.2022
Interrupting the treatment of vulnerable people on immune-suppressing medicines, doubles their antibody response to COVID-19 booster vaccination
Interrupting the treatment of vulnerable people on immune-suppressing medicines, doubles their antibody response to COVID-19 booster vaccination
A major clinical trial, led by experts at the University of Nottingham working in partnership with Universities and NHS hospitals including the University of Manchester , has found that by interrupting the treatment of vulnerable people on long-term immune suppressing medicines for two weeks after a COVID-19 booster vaccination, their antibody response to the jab is doubled.

Health - Pharmacology - 27.06.2022
MHH Sarcoma Center successfully DKG-certified
MHH Sarcoma Center successfully DKG-certified
Treatment of rare tumors: In addition to soft tissue tumors, the MHH is the only center in Lower Saxony to be certified for bone sarcomas.

Health - Pharmacology - 27.06.2022
The third wave of COVID-19 delivers the highest mortality risk in Australian ICUs
According to a new study led by Monash University, of those admitted to the ICU with COVID-19, after accounting for age and how sick patients were, the third wave of the disease in Australia was associated with the highest risk of dying in hospital, in comparison with earlier waves. Patients admitted to ICU during the third wave were mostly unvaccinated (75 per cent), younger than the previous two waves (24 per cent > 65 years of age), more likely to be pregnant and/or obese, and less likely to have co-morbid conditions.

Pharmacology - Health - 24.06.2022
Which patients with advanced prostate cancer will benefit from chemotherapy
Researchers have recommended changes to how cancer patients are treated, after a new UCL-led study discovered that chemotherapy is significantly more effective for some men with advanced prostate cancer than others.

Health - Pharmacology - 23.06.2022
Researchers Continue Study of COVID-19 Vaccinations, Pregnancy and Postpartum
Ten-million-dollar grant over four years will support further examination of COVID-19 vaccination safety during pregnancy and immune response pre-and post-delivery With the SARS-CoV-2 pandemic ongoin

Pharmacology - Health - 23.06.2022
U.S. rolls out COVID-19 vaccines for youngest children
The CDC and FDA approved vaccines by Moderna and Pfizer/BioNTech in children older than 6 months; vaccinations began this week U.S. children older than 6 months are now eligible to rece

Health - Pharmacology - 22.06.2022
COPD patients respond equally well to COVID-19 vaccine
COPD patients respond equally well to COVID-19 vaccine
A study which tested the immune response of COPD patients to COVID-19 vaccination has shown they respond in a similar way to healthy people.

Health - Pharmacology - 22.06.2022
The path to personalised hepatitis D treatment
The path to personalised hepatitis D treatment
EU supports multicentre project with a total of 6.75 million euros Hepatitis D is by far the most severe form of chronic viral hepatitis, often leading to liver failure, liver cancer and death.

Health - Pharmacology - 21.06.2022
COVID-19 Rebound after Taking Paxlovid Likely Due to Insufficient Drug Exposure
Paxlovid rebound patient did not show drug resistance or impaired immunity; UC San Diego study suggests insufficient drug exposure was most likely cause Paxlovid is the leading oral medication for preventing severe cases of COVID-19 in high-risk individuals.

Health - Pharmacology - 17.06.2022
Heart surgery delays will cost lives, warns research
Pandemic has delayed lifesaving treatment for thousands of people with severe aortic stenosis. Our approach does not put the onus on only management or doctors, but creates a joint solution that is easier to implement in practice Feryal Erhun Urgent action is needed to clear the backlog of people with a common heart condition who are waiting for lifesaving treatment, according to published in the journal BMJ Open .

Health - Pharmacology - 17.06.2022
Kawasaki Disease Rates Dropped During COVID-19 Pandemic
UC San Diego researchers report significant decrease in national cases of Kawasaki disease in 2020; findings hint at origins of disease Researchers at University of California San Diego School of Medicine, Scripps Institution of Oceanography and Rady Children's Hospital-San Diego teamed with partners across the United States to track rates of Kawasaki disease (KD) before and during the COVID-19 pandemic.

Health - Pharmacology - 16.06.2022
New system that defines Huntington’s Disease will ’revolutionise’ drug trials
A novel staging framework that assesses the progression of Huntington's disease (HD), similar to the way cancer is staged 0 to 4, has been developed by UCL scientists as part of an international consortium; paving the way for clinical trials of drugs in the earliest stages of HD.

Pharmacology - Health - 16.06.2022
Access to safer supply rapidly increased during COVID-19: study
Access to safer supply rapidly increased during COVID-19: study
Science, Health & Technology Kevin Hollett The number of programs and prescribers offering safer supply to reduce risk of overdose increased dramatically in the early days of the COVID-19 pandemic, according to a new study looking at services across Canada.

Health - Pharmacology - 16.06.2022
Peanut allergy treatment safest when started for infants under 12 months
Peanut allergy treatment safest when started for infants under 12 months
Science, Health & Technology Erik Rolfsen UBC researchers demonstrated in 2019 that pre-schoolers can safely overcome peanut allergies with a treatment called oral immunotherapy. Now they have evidence that the earlier pre-schoolers start this treatment, the better. This real-world study focused on infants younger than 12 months old and reveals that not only is oral immunotherapy effective against peanut allergies, it's even safer for this age group than it is for toddlers and older pre-schoolers.

Health - Pharmacology - 16.06.2022
Researchers in Glasgow to receive £1.9m to tackle late stage cancer syndrome
Scientists at the Cancer Research UK Beatson Institute and the University of Glasgow are to receive £1.9m to explore the causes of a debilitating wasting disease that many people experience in the later stages of cancer. The funding is from Cancer Grand Challenges, a research initiative co-founded by Cancer Research UK and the National Cancer Institute in the US, which aims to encourage the world's leading researchers to tackle the toughest challenges faced by cancer patients.

Health - Pharmacology - 16.06.2022
FDA approves COVID-19 vaccines for children under 5 years old. What’s next?
Johns Hopkins vaccine expert Ruth Karron discusses the authorization of COVID-19 vaccines for those under 5 years old, and what's likely to happen with the authorization over the next few weeks The U

Pharmacology - Health - 16.06.2022
What you need to know about the Novavax vaccine
What you need to know about the Novavax vaccine
Novavax uses a combination of spike proteins and an immune stimulant to provoke an immune response against the virus that causes COVID-19.

Pharmacology - Health - 15.06.2022
UK researchers pioneer new virtual treatment for PTSD
UK researchers pioneer new virtual treatment for PTSD
Researchers at Cardiff University have pioneered a new form of virtual treatment for people with post-traumatic stress disorder (PTSD).

Pharmacology - Health - 15.06.2022
$2.38M to test nano-engineered brain cancer treatment in mice
A protein that crosses the blood-brain barrier carries a drug that kills tumor cells and another that activates the immune system A new nanomedicine that crosses the blood-brain barrier, engages the

Chemistry - Pharmacology - 14.06.2022
Mulliken Center of the University of Bonn and Merck cooperate in machine learning project
The Mulliken Center for Theoretical Chemistry at the University of Bonn is collaborating with Merck.

Health - Pharmacology - 14.06.2022
Bakar Fellows program names seven new Spark Award recipients
Anna Harte is the medical director of University Health Services at UC Berkeley.

Health - Pharmacology - 13.06.2022

Health - Pharmacology - 10.06.2022

Health - Pharmacology - 09.06.2022
Three UC3M COVID-19 research projects receive funding from the Community of Madrid
The Universidad Carlos III de Madrid (UC3M) has received 4,859,000 euros from the Community of Madrid to fund three COVID-19 research projects.

Pharmacology - Health - 09.06.2022
Concerns about new mutations as vaccine willingness slightly decreases
Concerns about new mutations as vaccine willingness slightly decreases
Two-thirds of the German population are concerned about new corona mutations; one-fifth of the population is very worried.

Health - Pharmacology - 09.06.2022
More than $19.7m awarded to Monash researchers for vital medical research
The National Health and Medical Research Council (NHMRC) has announced more than $19. M in funding for Monash research projects that incorporate diabetes, epilepsy and seizures, infection management, alcohol treatment, acidic blood trial and a new device to deliver treatment to premature babies.

Health - Pharmacology - 08.06.2022
Major US award for Bern and Geneva researchers
Major US award for Bern and Geneva researchers
A prestigious grant from the USA goes to the biomedical scientist Sven Rottenberg, University of Bern, and the clinical scientist Intidhar Labidi-Galy, University of Geneva and University Hospital of Geneva.

Health - Pharmacology - 08.06.2022
The pandemic has reached a plateau, but for how long?
The pandemic has reached a plateau, but for how long?
Johns Hopkins health security expert Tom Inglesby provides an update on the state of the pandemic and how vaccination, funding, and variants may affect its future The U.S. appears to ha

Chemistry - Pharmacology - 08.06.2022
New delivery method allows slow-release of broader array of peptide drugs in the body 
New delivery method allows slow-release of broader array of peptide drugs in the body A new study from the University of Michigan describes one of the first entirely new drug delivery microencapsulation approaches in decades. Study: Efficient aqueous remote loading of peptides in poly(lactic-co-glycolic acid ) Microencapsulation in biodegradable polymers allows drugs such as peptide therapeutics to be released over time in the body.

Pharmacology - 07.06.2022
COVID-19 and Brexit 'caused sharp rise in copycat ecstasy'
COVID-19 and Brexit ’caused sharp rise in copycat ecstasy’
A new study has highlighted the apparent effect of Brexit and the pandemic on the trade in the illegal party drug ecstasy (MDMA). Researchers from The Loop, a UK drug checking charity, found almost half (45%) of substances sold as MDMA at English festivals last year contained none - and instead contained other drugs such as caffeine or cathinones.

Pharmacology - Health - 06.06.2022
Study identifies best treatment for rare childhood cancer
High doses of drug called ifosfamide are the best way to treat a cancer of children which affects bones and soft tissues, compared to three other treatments, according to University of Manchester researchers.

Health - Pharmacology - 06.06.2022
Causes of Liver Cancer are Changing Around the World: Some Up, Some Down
What isn-t changing is the steady rise in cases and deaths globally The primary causes of liver cancer are well known: viral (hepatitis B and C), alcohol and non-alcoholic steatohepatitis (NASH), a condition in which fat builds up in the liver, resulting in chronic inflammation and damage.

Psychology - Pharmacology - 01.06.2022
UCLA psychologist looks for new ways to treat alcohol addiction
UCLA psychologist looks for new ways to treat alcohol addiction
Lara Ray, professor of psychology at UCLA, has been studying alcohol use disorders since long before the COVID-19 pandemic. In 2008, she established the UCLA Addictions Lab to research medications and other treatments for those who want to quit or reduce their drinking. But a spike in alcohol consumption during the pandemic has brought substance abuse back into the spotlight.

Health - Pharmacology - 26.05.2022
Q&A: What you need to know about monkeypox
Q&A: What you need to know about monkeypox
Monkeypox burst into the headlines this month after cases were diagnosed in Africa, Europe, North America and Australia.

Pharmacology - Health - 26.05.2022
Researcher focuses on essential, but often-ignored, organ in pregnancy
The placenta is an essential organ for the developing fetus, both protecting the fetus from potentially harmful components in the blood and transferring nutrients needed for growth and development.

Pharmacology - Health - 25.05.2022
University spinout in major partnership to commercialize treatment for invasive aspergillosis
University spinout in major partnership to commercialize treatment for invasive aspergillosis
F2G, a University of Manchester spinout company, is to partner a major Japanese pharmaceutical company in the commercialisation of a novel antifungal treatment it developed for invasive aspergillosis and other rare mould infections.

Health - Pharmacology - 24.05.2022
Novel implant for the treatment of valvular heart disease
In a complex procedure, a team from the Department of Cardiac Surgery at MedUni Vienna and University Hospital Vienna has, for the first time, successfully inserted a novel implant for treating tricuspid valve regurgitation via a single access on one side of the groin.

Pharmacology - Health - 24.05.2022
Turning drug discovery into speed dating
Turning drug discovery into speed dating
EPFL spin-off ArcoScreen has developed a platform that turns the discovery of new drugs for Alzheimer's and Parkinson's disease, diabetes and cancer from a marathon into a sprint. The firm's microfluidic readout system assesses the response of G-protein-coupled receptors (GPCRs) to new substances, delivering significant time and financial gains for pharmaceutical companies.

Health - Pharmacology - 24.05.2022
What you need to know about monkeypox
What you need to know about monkeypox
As monkeypox spreads beyond its endemic locations, an infectious disease expert offers insight on how the virus spreads-and why it shouldn't be a cause for alarm Monkeypox is nothing new, and the virus is endemic in several countries.

Health - Pharmacology - 23.05.2022
How concerned should you be about monkeypox?
Monkeypox, a virus that causes pus-filled blisters, has been detected in several countries, including the United States, Canada, Australia and some European nations.

Health - Pharmacology - 20.05.2022
Scientists smash lethal bacteria that acts like a hammer
New research from The Australian National University (ANU) could lead to better treatment options for a rare but very lethal type of bacteria l'infection.
1 2 3 4 5 ... 60 Next »